This new drug may treat cancer, Alzheimer’s, heart disease, and more

In a new study, researchers found a new drug that holds exciting possibilities for the treatment of cancers and many other diseases.

The research was conducted by a team at Creighton University and UCLA.

The new drug HM-10/10 is developed from proteins used to diagnose ovarian cancer. It has been effective in inhibiting tumor growth in colorectal and ovarian cancers in mice.

HM-10/10 is an artificial peptide that mimics high-density lipoprotein (HDL), the so-called “good cholesterol.”

In the study, a group of lab mice that had consumed a diet that included the HM-10/10 peptide was found to have a much lower tumor load than mice that had not eaten the peptide.

The drug also shows the potential to treat other pro-inflammatory diseases, such as macular degeneration, heart disease, Alzheimer’s and endometriosis.

Prior to publishing on its effectiveness as a cancer treatment, the team published another paper showing HM-10/10’s potential to treat retinal disease (e.g. macular degeneration).

The team previously discovered the depletion of a certain protein, ApoA-1, in ovarian cancer patients created a hospitable environment for cancer to thrive.

With this in mind, the team created HM-10/10 using elements of the ApoA-1 protein alongside other constituent proteins.

The lead author of the study is Robin Farias-Eisner, MD, Ph.D.

The study is published in the Journal of Cancer Research and Therapeutic Oncology.

Copyright © 2020 Knowridge Science Report. All rights reserved.